CSHL scientists clarify editing error underlying genetic neurodegenerative disease

January 29, 2009

U1, which guides the cell's RNA splicing machinery, 'slides' one RNA base, explaining a mysterious mutation

Two molecular biologists at Cold Spring Harbor Laboratory have uncovered important new details about how a gene mutation causes a cellular editing error that results in a devastating disease called pontocerebellar hypoplasia (PCH). The new findings were published online, ahead of print, on January 25th in the journal Nature Structural and Molecular Biology.

Typically striking during early childhood, PCH is characterized by the slow wasting away of certain parts of the brain, resulting in abnormal brain function and cognitive impairment characteristic of mental retardation. Although scientists have known about the gene mutation that causes the disease, they haven't been able to explain why the mutation causes a defect in an essential cellular function called RNA splicing.

RNA splicing is an essential step in the process in cell nuclei whereby instructions encoded in DNA are transcribed to RNA copies, which subsequently leave the nucleus to serve as templates for the cellular machinery to manufacture protein molecules. The RNA intermediaries (called "messengers"), in order to function properly in this role, are typically "edited" by special enzymes, which perform a procedure analogous to the editing of frames in a film, where unnecessary frames are left out of the final version.

An 'atypical' splice site

The new discovery stems from a program of research by Professor Adrian Krainer, Ph.D., and members of his lab at CSHL, to understand how cells process the information encoded in genes. For reasons that remain poorly understood, the raw or unedited RNA copy of DNA includes excess RNA segments called introns that need to be edited out in order for the RNA's message to be functional. Once the introns are removed, the remaining segments -- called exons -- are pasted together, forming a mature messenger RNA transcript.

In an unedited RNA molecule, the boundaries between an intron and its two flanking exons are called splice sites. Such sites are composed of short sequences of RNA "letters" (called "bases"), which are referred to by single-letter molecular shorthands: A, U, G and C. The cell's RNA splicing machinery is correctly guided to the splice site at the beginning of an intron by one of its components, a small nuclear RNA called U1.

U1 recognizes this splice site by lining up against the target RNA and pairing a segment of its own RNA bases with the splice site's RNA bases following a set of rules: U pairs with A or G, and C pairs with G. U1's ability to recognize this splice site at the start of the intron is strongest when up to 11 bases are paired up.

When Krainer and postdoctoral researcher Xavier Roca, Ph.D., analyzed SpliceRack, a comprehensive database of all ~200,000 known, functional splice sites found at the beginning of every intron in human genes, they were surprised to find many of these sites that didn't appear to have the right sequence of RNA bases to match U1. Experimental testing of particular examples of these sites showed, however, that they were in fact recognized by U1 and effectively used. These "atypical" sites, in other words, could be spliced to make the correct messenger RNA, despite the apparent mismatch.

Atypical sites are recognized due to a shift in base-pairing

This raises the question: how does U1 manage to recognize such a diverse set of sequences, which include sequences that seem to be very poor matches to U1? The answer, Krainer and Roca have found, is explained in at least some cases by how U1 lines up with its target RNA.

"In the three decades since RNA splicing was discovered, scientists have believed that a functional match between U1 and its target RNA occurs only when the RNA bases in U1 and the target line up in a unique way," explains Roca. "We now find that this rule sometimes has exceptions."

The CSHL team has now demonstrated that U1 is more flexible in its binding than previously thought. Instead of only lining up in a manner such that a particular base in U1 pairs with the first base of the target intron's RNA sequence - that is, in the conventional way - the scientists have found that U1 can shift itself down to the next base in the intron's RNA sequence if this new arrangement allows more of U1's RNA bases to pair up with bases in the intron, thus producing a stronger match.

This phenomenon, which Krainer calls "shifting of the base-pairing," can be explained in terms of locks and keys. If the many different splice sites are thought of as different locks, then U1 is the master key that can open them all. Some locks don't match well with the master key at first try. But it has now been shown that if the key is shifted a bit so that more of the individual "serrations" of the "key" match those of the "locks," the key will work perfectly well.

Implications for Disease

This ability of U1 to slide down just a single RNA base to recognize an atypical splice site might seem like a slight adjustment, but disrupting this phenomenon can have pathological consequences.

In the specific context of the gene mutation implicated in PCH, base-pair shifting explains why this mutation causes a severe disease. Krainer and Roca's results indicate that the correct splice site of this gene is normally recognized by the sliding mechanism and not in the conventional way, as scientists had previously believed. The mutation disrupts this recognition, resulting in an abnormally "edited" RNA molecule. The "message" from the gene that is carried by the wrongly edited RNA, therefore, is faulty. This can result, in young children, in the onset of PCH.

The CSHL team's findings also have implications for studies aimed at uncovering and characterizing new disease-causing mutations, according to Krainer. "We expect to more accurately identify and understand certain splicing mutations that we may have previously overlooked," he explains.

Cold Spring Harbor Laboratory

---

---

	MRI best for carriers of BRCA gene mutations: study shows MRI detects more breast cancers in this population than do ultrasound or ... An article from: Family Practice News by Betsy Bates (Author) This digital document is an article from Family Practice News, published by International Medical News Group on December 1, 2004. The length of the article is 979 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: MRI best for carriers of BRCA gene mutations: study shows MRI detects more breast cancers in this population than do ultrasound or mammography.(Women's Health)(Magnetic resonance imaging) Author: Betsy Bates Publication: Family Practice News (Magazine/Journal) Date: December 1, 2004 Publisher: International Medical News Group Volume: 34 Issue: 23 Page:...
	Pneumocystis jiroveci Dihydropteroate Synthase Gene Mutations Among Colonized Individuals and Pneumocystis Pneumonia Patients From Spain (Postgraduate Medicine) by JTE Multimedia Cotrimoxazole, an association of trimethoprim and sulfamethoxazole, and dapsone, are mainstays for the prophylaxis and treatment of Pneumocystis pneumonia (PcP). The inability to culture Pneumocystis prevents routine susceptibility testing and detection of drug resistance. Instead, molecular techniques have been used to detect Pneumocystis jiroveci dihydropteroate synthase (DHPS) mutations that cause sulfa resistance in other microorganisms. The most frequent DHPS mutations occur at nucleotide positions 165 and 171, which lead to an amino acid change at positions 55 and 57. Several studies suggest that these mutations are associated with the failure of chemoprophylaxis for PcP. The aim was to establish the frequency and characteristics of P jiroveci DHPS mutations among colonized...
	Genetic Bypass: Using Nutrition To Bypass Genetic Mutations by Dr. Amy Yasko (Author) Provides background information on the value and usefullness of genetic testing as well as specific recommendations for analyzing and comprehending gene mutations.
	Muscle Gene Therapy: Methods and Protocols (Methods in Molecular Biology) by Dongsheng Duan (Editor) Gene therapy offers many conceptual advantages to treat muscle diseases, especially various forms of muscular dystrophies; however, it faces a number of unique challenges, including the need to deliver a therapeutic vector to all muscles throughout the body. In Muscle Gene Therapy: Methods and Protocols, expert researchers in the field present a collection of techniques aimed at bridging the translational gap in muscle gene therapy between the prevalent rodent models and vitally important larger animal models. Divided into three sections, this volume examines basic protocols for optimizing the muscle gene expression cassette and for evaluating the therapeutic outcomes, new developments in muscle gene therapy technology such as adeno-associated viral vector (AAV),...
	Human Gene Mutation (Human Molecular Genetics Series.) by David N. Cooper (Author), Michael Krawczak (Author) Globetrotter Travel Packs offer exceptional value for money by combining Guide and Map in a pocket-sized plastic wallet. -- Fresh new series look -- All the information you need on a destination in one handy pack -- Exceptional value for money
	21st Century Genetics Reference Handbook - Guide to Understanding Genetic Conditions, DNA, Mutations, Chromosomal Changes, Genetic Testing, Gene Therapy, Human Genome Project, Genomic Research by Progressive Management This unique guide provides authoritative information about genetics and related issues impacting health and medicine: Cells and DNA * Cells, genes, and chromosomes * How Genes Work * Proteins, cell growth, and cell division * Mutations and Health * Gene mutations, chromosomal changes, and conditions that run in families * Inheriting Genetic Conditions * Inheritance patterns and understanding risk * Genetic Consultation * Finding and visiting a genetic counselor or other genetics professional * Genetic Testing * Benefits, costs, risks, and limitations of genetic testing * Gene Therapy * Experimental techniques, safety, ethics, and availability * The Human Genome Project * Sequencing and understanding the human genome * Genomic Research * Next steps in studying the human...
	Lewin's Genes X by Jocelyn E. Krebs (Author), Elliott S. Goldstein (Author), Stephen T. Kilpatrick (Author) The field of molecular biology and molecular genetics is rapidly changing with new data acquired daily and new insights into well-studied processes presented on a scale of weeks or months rather than years. For decades Lewin's GENES has provided the teaching community with the most cutting edge presentation of molecular biology and molecular genetics, covering gene structure, sequencing, organization, and expression. The latest edition, with a knowledgeable new author team, has enlisted 21 scientists to provide revisions and content updates in their individual fields of expertise, ensuring that Lewin's GENES X is the most current and comprehensive text in the field. Informative new chapters, as well as a reorganization of material, provide a more logical flow of topics and many chapters...
	Gene Discovery for Disease Models by Weikuan Gu (Editor), Yongjun Wang (Editor) This book provides readers with new paradigms on the mutation discovery in the post-genome era. The completion of human and other genome sequencing, along with other new technologies, such as mutation analysis and microarray, has dramatically accelerated the progress in positional cloning of genes from mutated models. In 2002, the Mouse Genome Sequencing Consortium stated that “The availability of an annotated mouse genome sequence now provides the most efficient tool yet in the gene hunter's toolkit. One can move directly from genetic mapping to identification of candidate genes, and the experimental process is reduced to PCR amplification and sequencing of exons and other conserved elements in the candidate interval. With this streamlined protocol, it is anticipated that many...
	Disease Gene Identification: Methods and Protocols (Methods in Molecular Biology) by Johanna K. DiStefano (Editor) Recent efforts to characterize genetic variation in the human genome, coupled with the rapidly developing field of genomics, have lead directly to the development of new and innovative approaches to the identification of genes contributing to complex human diseases. In Disease Gene Identification: Methods and Protocols, expert researchers in the field provide up-to-date molecular methodologies used in the process of identifying a disease gene, from the initial stage of study design to the next stage of preliminary locus identification, and ending with stages involved in target characterization and validation. As a volume in the highly successful Methods in Molecular Biology™ series, chapters contain brief introductions to their respective topics, lists of the necessary materials and...
	Frequency of the 35delG mutation in the GJB2 gene in samples of European, Asian, and African Brazilians.: An article from: Human Biology by C.A. Oliveira (Author), F. Alexandrino (Author), K. Abe-Sandes (Author), W.A. Silva (Author), A.T. Maciel-Guerra (Author), L.A. Magna (Author), E.L. Sartorato (Author) This digital document is an article from Human Biology, published by Wayne State University Press on April 1, 2004. The length of the article is 1423 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. From the author: KEY WORDS: GJB2, BRAZILIAN POPULATION, CONGENITAL DEAFNESS Citation Details Title: Frequency of the 35delG mutation in the GJB2 gene in samples of European, Asian, and African Brazilians. Author: C.A. Oliveira Publication: Human Biology (Refereed) Date: April 1, 2004 Publisher: Wayne State University Press Volume: 76 Issue: 2 Page: 313(4) Distributed by...